Border controlled precursors
16 Border controlled precursors
Each item of the following table lists:
for the purposes of paragraph 301.6(1)(a) of the Code, a substance that is a border controlled precursor; and
for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity (if any) that is the commercial quantity of the border controlled precursor; and
for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity (if any) that is the marketable quantity of the border controlled precursor.
A salt or ester of a substance listed in the table and an immediate precursor of a substance listed in the table are also border controlled precursors: see paragraphs 301.6(1)(b) and (c) of the Code.
Border controlled precursors and quantities | |||
|---|---|---|---|
Item | Border controlled precursor | Commercial quantity (kilograms) | Marketable quantity (grams) |
1 | N‑Acetylanthranilic acid | ||
1A | Alpha‑Phenylacetoacetamide (APAA) | 2.74 | 7.3 |
1B | Alpha‑Phenylacetoacetonitrile (APAAN) | 1.76 | 4.7 |
1C | 4‑Anilino‑N‑phenethylpiperidine (ANPP) | 0.006 | 0.006 |
2 | Any plant of the species Ephedra | ||
2AA | Butyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate | 1.46 | 14.6 |
2AB | Butyl 3‑phenyl‑2‑methyl glycidate | 3.61 | 9.6 |
2A | Chloroephedrine | 1.153 | 3.07 |
2B | Chloropseudoephedrine | 1.153 | 3.07 |
2C | Diethyl 2‑(2‑phenylacetyl)propanedioate (DEPAPD) | 4.75 | 12.7 |
3 | Ephedrine | 1.2 | 3.2 |
4 | Ergometrine | 0.006 | 0.006 |
5 | Ergotamine | 0.01 | 0.01 |
5A | Ethyl alpha‑phenylacetoacetate (EAPA) | 3.28 | 8.8 |
5B | Ethyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate | 1.3 | 13.0 |
5C | Ethyl 3‑phenyl‑2‑methyl glycidate | 3.18 | 8.5 |
5D | Isobutyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate | 1.46 | 14.6 |
5E | Isobutyl 3‑phenyl‑2‑methyl glycidate | 3.61 | 9.6 |
5F | Isopropyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate | 1.38 | 13.8 |
5G | Isopropyl 3‑phenyl‑2‑methyl glycidate | 3.39 | 9.1 |
6 | Isosafrole | 1.45 | 1.45 |
7 | Lysergic acid | 0.003 | 0.003 |
7A | Methyl alpha‑phenylacetoacetate (MAPA) | 3.06 | 8.2 |
7AA | 3‑(3’,4’‑Methylenedioxyphenyl)‑2‑methyl glycidic acid | 1.33 | 13.3 |
7B | 3‑(3’, 4’‑Methylenedioxyphenyl)‑2‑methyl glycidic acid, sodium salt (NaMDMG) | 1.46 | 14.6 |
8 | 3,4‑Methylenedioxyphenyl‑2‑propanone | 0.75 | 0.75 |
8A | Methyl 3‑(3’, 4’‑methylenedioxyphenyl)‑2‑methyl glycidate (MMDMG) | 1.23 | 12.3 |
8B | Methyl 3‑phenyl‑2‑methyl glycidate | 2.96 | 7.9 |
8BA | Norfentanyl | 0.006 | 0.006 |
8C | N‑Phenethyl‑4‑piperidone (NPP) | 0.008 | 0.008 |
9 | Phenylacetic acid | 4.05 | 10.8 |
9AA | 3‑Phenyl‑2‑methyl glycidic acid | 4.6 | 12.2 |
9A | 3‑Phenyl‑2‑methyl glycidic acid, sodium salt | 5.17 | 13.7 |
9B | N‑Phenyl‑4‑piperidinamine (4‑AP) | 0.008 | 0.008 |
10 | Phenylpropanolamine | 1.2 | 3.2 |
11 | Phenyl‑2‑propanone | 1.04 | 2.7 |
11A | Phenyl‑2‑propanone bisulphite | 2.64 | 7.04 |
11B | 1‑Phenylpropan‑2‑yl 4‑methylbenzenesulfonate (para‑tosyl‑phenyl‑2‑propanol) | 2.25 | 5.9 |
11C | 4‑Piperidone | 0.008 | 0.008 |
12 | Piperonal | 1.6 | 1.6 |
12A | Propyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate | 1.38 | 13.8 |
12B | Propyl 3‑phenyl‑2‑methyl glycidate | 3.39 | 9.1 |
13 | Pseudoephedrine | 1.2 | 3.2 |
14 | Safrole | 2.85 | 2.85 |
15 | sec‑Butyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate | 1.46 | 14.6 |
16 | sec‑Butyl 3‑phenyl‑2‑methyl glycidate | 3.61 | 9.6 |
17 | N‑(tert‑Butoxycarbonyl)‑4‑piperidone | 0.015 | 0.015 |
18 | tert‑Butyl 3‑(3’,4’‑methylenedioxyphenyl)‑2‑methyl glycidate | 1.46 | 14.6 |
19 | tert‑Butyl 4‑(phenylamino) piperidine‑1‑carboxylate (1‑boc‑4‑AP) | 0.015 | 0.015 |
20 | tert‑Butyl 3‑phenyl‑2‑methyl glycidate | 3.61 | 9.6 |
Restricted listing
Each item of the following table lists:
for the purposes of paragraph 301.6(1)(a) and subsection 301.6(1A) of the Code, a substance that is taken to be a border controlled precursor only in relation to the following:
an offence against subsection 307.11(1), 307.12(1) or 307.13(1) of the Code, if the offence relates to importing a substance;
an offence against subsection 309.14(1) or 309.15(1) of the Code, if the offence relates to procuring an individual to import a substance; and
for the purposes of paragraph (a) of item 1 of the table in section 301.10 of the Code, the quantity that is the commercial quantity of the border controlled precursor; and
for the purposes of paragraph (a) of item 1 of the table in section 301.11 of the Code, the quantity that is the marketable quantity of the border controlled precursor.
For a salt, ester or immediate precursor of a substance listed in the table, see paragraphs 301.6(1)(b) and (c) and subsection 301.6(1B) of the Code.
Border controlled precursors and quantities—restricted listing | |||
|---|---|---|---|
Item | Border controlled precursor | Commercial quantity (kilograms) | Marketable quantity (grams) |
1 | Alpha‑Methyl‑1,3‑benzodioxole‑5‑propanal (Helional) | 1.0 | 1.0 |
2 | Benzaldehyde | 1.85 | 4.8 |
3 | Hypophosphorous acid (Phosphinic acid) | 1.2 | 3.2 |
4 | Iodine | 1.2 | 3.2 |
5 | Methylamine | 0.6 | 1.6 |
This Act’s bill:Explanatory statement
The statute text is free to read above. View subscription options to unlock the case-law research tools for each provision.